Dainippon Sumitomo Starts Joint Research With Osaka University
This article was originally published in PharmAsia News
Executive Summary
Dainippon Sumitomo announced Oct. 23 that the company will collaborate with Osaka University on neuroscience research. The company will establish a neuropsychiatry drug discovery consortium with five divisions of the university's medical and pharmaceutical schools. The first research phase is planned for three years, from November 2008 to October 2011, and the company plans to invest ¥300 million in the project. Osaka University has conducted gene level research and aims to develop new drugs based on the research through forming alliances with pharmaceutical companies. (Click here for more - Japanese language)